FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890857066> ?p ?o ?g. }

• W2890857066 endingPage "862" @default.
• W2890857066 startingPage "855" @default.
• W2890857066 abstract "Background and Aims ERCP is a complex procedure often performed in patients at high risk for sedation-related adverse events (SRAEs). However, there is no current standard of care with regard to mode of sedation and airway management during ERCP. The aim of this study was to assess the safety of general endotracheal anesthesia (GEA) versus propofol-based monitored anesthesia care (MAC) without endotracheal intubation in patients undergoing ERCP at high risk for SRAEs. Methods Consecutive patients undergoing ERCP at high risk for SRAEs at a single center were invited to participate in this randomized controlled trial comparing GEA and MAC. Inclusion criteria were STOP-BANG score ≥3, abdominal ascites, body mass index ≥35, chronic lung disease, American Society of Anesthesiologists class >3, Mallampati class 4 airway, and moderate to heavy alcohol use. Exclusion criteria were preceding EUS, emergent ERCP, tracheostomy, unstable airway, gastric outlet obstruction or delayed gastric emptying, and altered foregut anatomy. The primary endpoint was composite incidence of SRAEs: hypoxemia, use of airway maneuvers, hypotension requiring vasopressors, sedation-related procedure interruption, cardiac arrhythmia, and respiratory failure. Secondary outcomes included procedure duration, cannulation success, in-room time, and immediate adverse events. Results Two hundred patients (mean age, 61.1 ± 13.6 years; 36.5% women) were randomly assigned to GEA (n = 101) or MAC (n = 99) groups. Composite SRAEs were significantly higher in the MAC group compared with the GEA group (51.5% vs 9.9%, P < .001). This was primarily driven by the frequent need for airway maneuvers in the MAC group. Additionally, ERCP was interrupted in 10.1% of patients in the MAC group to convert to GEA because of respiratory instability refractory to airway maneuvers (n = 8) or significant retained gastric contents (n = 2). There were no statistically significant differences in cannulation, in-room, procedure, or fluoroscopy times between the 2 groups. All patients undergoing GEA were successfully extubated in the procedure room at completion of ERCP, and Aldrete scores in recovery did not differ between the 2 groups. There were no immediate adverse events. Conclusion In patients at high risk for SRAEs undergoing ERCP, sedation with GEA is associated with a significantly lower incidence of SRAEs, without impacting procedure duration, success, recovery, or in-room time. These data suggest that GEA should be used for ERCP in patients at high risk for SRAEs (Clinical trial registration number: NCT02850887.) ERCP is a complex procedure often performed in patients at high risk for sedation-related adverse events (SRAEs). However, there is no current standard of care with regard to mode of sedation and airway management during ERCP. The aim of this study was to assess the safety of general endotracheal anesthesia (GEA) versus propofol-based monitored anesthesia care (MAC) without endotracheal intubation in patients undergoing ERCP at high risk for SRAEs. Consecutive patients undergoing ERCP at high risk for SRAEs at a single center were invited to participate in this randomized controlled trial comparing GEA and MAC. Inclusion criteria were STOP-BANG score ≥3, abdominal ascites, body mass index ≥35, chronic lung disease, American Society of Anesthesiologists class >3, Mallampati class 4 airway, and moderate to heavy alcohol use. Exclusion criteria were preceding EUS, emergent ERCP, tracheostomy, unstable airway, gastric outlet obstruction or delayed gastric emptying, and altered foregut anatomy. The primary endpoint was composite incidence of SRAEs: hypoxemia, use of airway maneuvers, hypotension requiring vasopressors, sedation-related procedure interruption, cardiac arrhythmia, and respiratory failure. Secondary outcomes included procedure duration, cannulation success, in-room time, and immediate adverse events. Two hundred patients (mean age, 61.1 ± 13.6 years; 36.5% women) were randomly assigned to GEA (n = 101) or MAC (n = 99) groups. Composite SRAEs were significantly higher in the MAC group compared with the GEA group (51.5% vs 9.9%, P < .001). This was primarily driven by the frequent need for airway maneuvers in the MAC group. Additionally, ERCP was interrupted in 10.1% of patients in the MAC group to convert to GEA because of respiratory instability refractory to airway maneuvers (n = 8) or significant retained gastric contents (n = 2). There were no statistically significant differences in cannulation, in-room, procedure, or fluoroscopy times between the 2 groups. All patients undergoing GEA were successfully extubated in the procedure room at completion of ERCP, and Aldrete scores in recovery did not differ between the 2 groups. There were no immediate adverse events. In patients at high risk for SRAEs undergoing ERCP, sedation with GEA is associated with a significantly lower incidence of SRAEs, without impacting procedure duration, success, recovery, or in-room time. These data suggest that GEA should be used for ERCP in patients at high risk for SRAEs (Clinical trial registration number: NCT02850887.)" @default.
• W2890857066 created "2018-09-27" @default.
• W2890857066 creator A5013228923 @default.
• W2890857066 creator A5039309088 @default.
• W2890857066 creator A5042550027 @default.
• W2890857066 creator A5067749370 @default.
• W2890857066 creator A5072000754 @default.
• W2890857066 creator A5074976792 @default.
• W2890857066 creator A5075015142 @default.
• W2890857066 creator A5075701151 @default.
• W2890857066 creator A5076306414 @default.
• W2890857066 creator A5081860468 @default.
• W2890857066 date "2019-04-01" @default.
• W2890857066 modified "2023-10-11" @default.
• W2890857066 title "A randomized controlled trial evaluating general endotracheal anesthesia versus monitored anesthesia care and the incidence of sedation-related adverse events during ERCP in high-risk patients" @default.
• W2890857066 cites W1968714831 @default.
• W2890857066 cites W1986286802 @default.
• W2890857066 cites W1990515920 @default.
• W2890857066 cites W1996435587 @default.
• W2890857066 cites W2000751827 @default.
• W2890857066 cites W2009410266 @default.
• W2890857066 cites W2031445122 @default.
• W2890857066 cites W2040770146 @default.
• W2890857066 cites W2059701823 @default.
• W2890857066 cites W2066737309 @default.
• W2890857066 cites W2085171426 @default.
• W2890857066 cites W2092435291 @default.
• W2890857066 cites W2093467790 @default.
• W2890857066 cites W2098906530 @default.
• W2890857066 cites W2107826751 @default.
• W2890857066 cites W2122813621 @default.
• W2890857066 cites W2123366884 @default.
• W2890857066 cites W2125397756 @default.
• W2890857066 cites W2130703694 @default.
• W2890857066 cites W2148823292 @default.
• W2890857066 cites W2319665427 @default.
• W2890857066 cites W2464654871 @default.
• W2890857066 cites W2781526186 @default.
• W2890857066 cites W2783938841 @default.
• W2890857066 cites W4253096148 @default.
• W2890857066 doi "https://doi.org/10.1016/j.gie.2018.09.001" @default.
• W2890857066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30217726" @default.
• W2890857066 hasPublicationYear "2019" @default.
• W2890857066 type Work @default.
• W2890857066 sameAs 2890857066 @default.
• W2890857066 citedByCount "54" @default.
• W2890857066 countsByYear W28908570662019 @default.
• W2890857066 countsByYear W28908570662020 @default.
• W2890857066 countsByYear W28908570662021 @default.
• W2890857066 countsByYear W28908570662022 @default.
• W2890857066 countsByYear W28908570662023 @default.
• W2890857066 crossrefType "journal-article" @default.
• W2890857066 hasAuthorship W2890857066A5013228923 @default.
• W2890857066 hasAuthorship W2890857066A5039309088 @default.
• W2890857066 hasAuthorship W2890857066A5042550027 @default.
• W2890857066 hasAuthorship W2890857066A5067749370 @default.
• W2890857066 hasAuthorship W2890857066A5072000754 @default.
• W2890857066 hasAuthorship W2890857066A5074976792 @default.
• W2890857066 hasAuthorship W2890857066A5075015142 @default.
• W2890857066 hasAuthorship W2890857066A5075701151 @default.
• W2890857066 hasAuthorship W2890857066A5076306414 @default.
• W2890857066 hasAuthorship W2890857066A5081860468 @default.
• W2890857066 hasConcept C105922876 @default.
• W2890857066 hasConcept C126322002 @default.
• W2890857066 hasConcept C141071460 @default.
• W2890857066 hasConcept C168563851 @default.
• W2890857066 hasConcept C197934379 @default.
• W2890857066 hasConcept C203092338 @default.
• W2890857066 hasConcept C2776277131 @default.
• W2890857066 hasConcept C2776779939 @default.
• W2890857066 hasConcept C2776814716 @default.
• W2890857066 hasConcept C2778333281 @default.
• W2890857066 hasConcept C2778716859 @default.
• W2890857066 hasConcept C42219234 @default.
• W2890857066 hasConcept C71924100 @default.
• W2890857066 hasConceptScore W2890857066C105922876 @default.
• W2890857066 hasConceptScore W2890857066C126322002 @default.
• W2890857066 hasConceptScore W2890857066C141071460 @default.
• W2890857066 hasConceptScore W2890857066C168563851 @default.
• W2890857066 hasConceptScore W2890857066C197934379 @default.
• W2890857066 hasConceptScore W2890857066C203092338 @default.
• W2890857066 hasConceptScore W2890857066C2776277131 @default.
• W2890857066 hasConceptScore W2890857066C2776779939 @default.
• W2890857066 hasConceptScore W2890857066C2776814716 @default.
• W2890857066 hasConceptScore W2890857066C2778333281 @default.
• W2890857066 hasConceptScore W2890857066C2778716859 @default.
• W2890857066 hasConceptScore W2890857066C42219234 @default.
• W2890857066 hasConceptScore W2890857066C71924100 @default.
• W2890857066 hasIssue "4" @default.
• W2890857066 hasLocation W28908570661 @default.
• W2890857066 hasLocation W28908570662 @default.
• W2890857066 hasOpenAccess W2890857066 @default.
• W2890857066 hasPrimaryLocation W28908570661 @default.
• W2890857066 hasRelatedWork W1843147913 @default.
• W2890857066 hasRelatedWork W1967433557 @default.
• W2890857066 hasRelatedWork W2049479517 @default.
• W2890857066 hasRelatedWork W2354276920 @default.
• W2890857066 hasRelatedWork W2369770283 @default.

• next